Today in IBD: Managing IBD in the Era of Covid-19

Today in IBD: Managing IBD in the Era of Covid-19 is organized by Haymarket Media Group.

Released: July 23, 2020
Expires: July 23, 2021

Target Audience:
Gastroenterology physicians, fellows, nurse practitioners, and physician assistants involved in the management of patients with inflammatory bowel disease

Accreditation:
American Academy of CME, Inc., designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Academy of CME, Inc., designates this educational activity for 1.5 contact hours (.9 pharmacotherapeutic contact hours).

California: Provider approved by the California Board of Registered Nursing, Provider Number CEP16993 for 1.5 contact hours.

American Academy of CME, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until July 23, 2021. PAs should only claim credit commensurate with the extent of their participation.

Description:
Managing Inflammatory Bowel Disease (IBD) in the Era of COVID-19 will thoroughly review the multi-society global recommendations for assessment and management of IBD during the coronavirus pandemic. This includes data on the evolving epidemiology of COVID-19, and specifically what is known about it in patients with IBD. It will provide state-of-the-art education regarding best-practices for telehealth and other non-endoscopic and distance management strategies, evidence supporting non-invasive monitoring of both disease activity and anti-inflammatory therapies, and strategies for de-intensification, cessation, and restarting IBD therapies safely and effectively during this unique and challenging time. Key topics of this timely webinar include: Overview of SARS-CoV-2; COVID-19 and IBD; The optimum management of IBD during the SARS-CoV-2 pandemic; Best practices for telehealth now and into the future; Monitoring patients with IBD during extraordinary times.

Objectives Topics:
After successful completion of this CME/CE activity, participating members of the IBD care team should be better able to:
• Identify the specific concerns and considerations of patients with IBD during the COVID-19 pandemic
• Develop standard testing and treatment protocols for IBD patients with known or suspected infection with SARS-CoV-2
• Incorporate non-invasive disease monitoring strategies into the management of IBD to assess remission and risks of clinical relapse
• Develop appropriate methods to de-intensify, stop, and restart medical therapies in IBD patients with known or suspected infection with SARS-CoV-2